Effects of low-dose beraprost sodium, a stable prostaglandin I2 analogue, on reperfusion injury to rabbit lungs

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 PART I, 1998, Pages 1669-1675

  Jiang, Xiao Wen ^a,b   Kambara, Kenjiro ^a   Gotoh, Naoki ^a   Nishigaki, Kazuhiko ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; CYCLIC AMP; PROSTACYCLIN DERIVATIVE; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; LUNG INJURY; LUNG PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; VASCULAR RESISTANCE;

EID: 0031762980     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.5.9609082     Document Type: Article

References (35)

1. Kennedy, T. P., N. V. Rao, C. Hopkins, L. Pennington, E. Tolley, and J. R. Hoidal. 1989. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J. Clin. Invest. 83:1326-1335.
2. Adkins, W. K., and A. E. Taylor. 1990. Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J. Appl. Physiol. 69:2012-2018.
3. Bysani, G. K., T. P. Kennedy, N. Ky, N. V. Rao, C. A. Blaze, and J. R. Hoidal. 1990. Role of cytochrome p-450 in reperfusion injury of the rabbit lung. J. Clin. Invest. 86:1434-1441.
4. Seibert, A. F., J. Haynes, and A. Taylor. 1993. Ischemia-reperfusion injury in the isolated rat lung; role of flow and endogenous leukocytes. Am. Rev. Respir. Dis. 147:270-275.
5. Moore, T. M., P. Khimenko, W. K. Adkins, M. Miyasaka, and A. E. Taylor. 1995. Adhesion molecules contribute to ischemia and reperfusion-induced injury in the isolated rat lung. J. Appl. Physiol. 78:2245-2252.
6. Barnard, J. W., A. F. Seibert, V. R. Prasad, D. A. Smart, S. J. Strada, A. E. Taylor, and W. J. Thompson. 1994. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor. J. Appl. Physiol. 77:774-781.
7. Adkins, W. K., J. W. Barnard, S. May, A. F. Seibert, J. Haynes, and A. E. Taylor. 1992. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J. Appl. Physiol. 72:492-497.
8. Khimenko, P. L., T. M. Moore, P. S. Wilson, and A. E. Taylor. 1996. Role of calmodulin and myosin light-chain kinase in lung ischemia-reperfusion injury. Am. J. Physiol 271:L121-L125.
9. Wickersham, N. E., J. J. Johnson, B. O. Meyrick, R. J. Gilroy, and J. E. Loyd. 1991. Lung ischemia-reperfusion injury in awake sheep: protection with verapamil. J. Appl. Physiol. 71:1554-1562.
10. Ljungman, A. G., C. M. Grum, G. M. Deeb, S. F. Bolling, and M. L. Morganroth. 1991. Inhibition of cyclooxygenase metabolite production attenuates ischemia-reperfusion lung injury. Am. Rev. Respir. Dis. 143:610-617.
11. Gurtner, G. H., I. S. Farrukh, N. F. Adkinson Jr., A. M. Sciuto, J. M. Jacobson, and J. R. Michael. 1987. The role of arachidonate mediators in peroxide-induced lung injury. Am. Rev. Respir. Dis. 136:480-483.
12. Garcia, J. G. N., and V. Natarajan. 1992. Mechanisms of transmembrane signal transduction and activation of phospholipases in vascular endothelium: implication for lung inflammation. In A. Johnson and T. J. Ferro, editors. Lung Vascular Injury. Marcel Dekker, New York. 1-66.
13. Balkhy, H. H., M. B. Peterson, R. J. Connolly, X. I. Zhang, and J. T. Diehl. 1995. Comparison of eurocollins and university of Wisconsin solution in single flush preservation of the ischemic reperfused lung: an in vivo rabbit model. Transplantation 59:1090-1095.
14. 2 analogue and prostacyclin on lung fluid balance in newborn Iambs. Circ. Res. 1409-1416.
15. Krausz, M. M., T. Utsunomiya, L. L. Levine, B. Dunham, D. Shepro, and H. B. Hechtman. 1982. Adverse effects of prostacyclin used to perfuse isolated lung lobes. Am. J. Physiol. 242:H745-H750.
16. Ogletree, M. L. 1982. Pharmacology of prostaglandins in the pulmonary microcirculation. Ann. N. Y. Acad. Sci. 384:191-206.
17. Yoshimura, K., M. L. Tod, K. G. Pier, and L. J. Rubin. 1989. Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs. J. Appl. Physiol. 66:929-935.
18. Palace, G. P., P. J. D. Vecchio, M. J. Morgan, and A. B. Malik. 1993. Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am. Rev. Respir. Dis. 147:143-147.
19. 2 analogue OP-2507 in the isolated perfused rat lung. J. Anesth. 8:450-454.
20. Hooper, T. L., D. S. Thompson, M. T. Jones, L. Cook, S. Owen, S. Wilkes, A. Woodcock, A. H. Webster, P. Hasleton, C. S. Campbell, A. N. Rahman, and G. A. McGregor. 1990. Amelioration of lung ischemic injury with prostacyclin. Transplantation 49:1031-1035.
21. 1. Am. Rev. Respir. Dis. 148:882-889.
22. Hooper, T. L., G. J. Fetherston, P. A. Flecknell, J. H. Dark, and C. G. A. McGregor. 1990. The use of a prostacyclin analogue, Iloprost, as an adjunct to pulmonary preservation with eurocollins solution. Transplantation 49:495-499.
23. Murata, T., T. Murai, T. Kanai, Y. Ogaki, K. Sanai, H. Kanda, S. Sato, N. Kajikawa, T. Umetsu, H. Matuura, Y. Fukatsu, M. Isogaya, N. Yamada, and S. Nishio. 1989. General pharmacology of berapost sodium, 2nd communication; effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects. Arzneim. Forsch./Drug Res. 39:867-876.
24. Kainoh, M., R. Imai, T. Umetsu, M. Hattori, and S. Nishio. 1990. Prosta-cyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes. Biochem. Pharmacol. 39:477-483.
25. Kraft, S. A., S. Fujishima, G. P. McGuire, J. S. Thompson, T. A. Raffin, and R. G. Pearl. 1995. Effect of blood and albumin on pulmonary hypertension and edema in perfused rabbit lungs. J. Appl. Physiol. 78:499-504.
26. 2 prevents monocrotaline-induced thromboxane production and lung injury. J. Appl. Physiol. 60:464-471.
27. Shen, C.-Y., D. Wang, M.-L. Chang, and K. Hsu. 1995. Protective effect of mepacrine on hypoxia-reoxygenation-induced acute lung injury in rats. J. Appl. Physiol 78:225-231.
28. Farrukh, I. S., G. H. Gurtner, and J. R. Michael. 1987. Pharmacological modification of pulmonary vascular injury: possible role of cAMP. J. Appl. Physiol. 62:47-54.
29. Mizus, I., W. Summer, I. Farrukh, J. R. Michael, and G. H. Gurtner. 1985. Isoproterenol or aminophylline attenuate pulmonary edema after acid lung injury. Am. Rev. Respir. Dis. 131:256-259.
30. Minnear, F. L., A. Johnson, and A. B. Malik. 1986. β-adrenergic modulation of pulmonary transvascular fluid and protein exchange. J. Appl. Physiol. 60:266-274.
31. Kobayashi, H., T. Kobayashi, and M. Fukushima. 1987. Effects of dibutyryl cAMP on pulmonary air embolism-induced lung injury in awake sheep. J. Appl. Physiol. 63:2201-2207.
32. Chang, S. W., A. Sasaki, and N. F. Voelkel. 1989. Dibutyryl-cAMP blocks endotoxin-induced lung injury in rats. Am. Rev. Respir. Dis. 140:1814-1817.
33. Imai-Sasaki, R., M. Kainoh, E. Ogawa, E. Ohmori, Y. Asai, and T. Nakadate. 1995. Inhibition of beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability. Prostagland. Lettkotrienes Essent. Fatty Acids 53:103-108.
34. Kuehl, F. A., M. E. Zanetti, D. D. Soderman, D. K. Miller, and E. A. Ham. 1987. Cyclic AMP-dependent regulation of lipid mediators in white cells. Am. Rev. Respir. Dis. 136:210-213.
35. 2 analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries. Naunyn-Schmiedeberg's Arch. Pharmacol. 311:67-70.